An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide

Journal of Lipid Research

Volumn 50, Issue 9, 2009, Pages 1889-1900

  Wool, Geoffrey D ^a   Vaisar, Tomas ^b   Reardon, Catherine A ^a   Getz, Godfrey S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Apolipoprotein A I; Cholesterol; High density lipoprotein; Inflammation; Oxidation; Synthetic peptides

Indexed keywords

AMYLOID A PROTEIN; APOLIPOPROTEIN A1; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PROLINE;

ACETYLATION; ALPHA HELIX; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN STRUCTURE; SURFACE PLASMON RESONANCE;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOLIPOPROTEIN A-I; BIOTINYLATION; FEMALE; HEMOGLOBINS; HUMANS; KINETICS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDES; PROLINE; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SUBSTRATE SPECIFICITY;

EID: 68749118094     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M900151-JLR200     Document Type: Article

References (28)

1. Anantharamaiah, G. M., V. K. Mishra, D. W. Garber, G. Datta, S. P. Handattu, M. N. Palgunachari, M. Chaddha, M. Navab, S. T. Reddy, J. P. Segrest, et al. 2007. Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides. J. Lipid Res. 48: 1915-1923.
2. Navab, M., G. M. Anantharamaiah, S. T. Reddy, S. Hama, G. Hough, V. R. Grijalva, N. Yu, B. J. Ansell, G. Datta, D. W. Garber, et al. 2005. Apolipoprotein A-I mimetic peptides. Arterioscler. Thromb. Vasc. Biol. 25: 1325-1331.
3. Wool, G. D., C. A. Reardon, and G. S. Getz. 2008. Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties. J. Lipid Res. 49: 1268-1283.
4. Sankararamakrishnan, R., and S. Vishveshwara. 1990. Conformational studies on peptides with proline in the right-handed alpha-helical region. Biopolymers. 30: 287-298.
5. Barlow, D. J., and J. M. Thornton. 1988. Helix geometry in proteins. J. Mol. Biol. 201: 601-619.
6. Garber, D. W., Y. V. Venkatachalapathi, K. B. Gupta, J. Ibdah, M. C. Phillips, J. B. Hazelrig, J. P. Segrest, and G. M. Anantharamaiah. 1992. Turnover of synthetic class A amphipathic peptide analogues of exchangeable apolipoproteins in rats. Correlation with physical properties. Arterioscler. Thromb. 12: 886-894.
7. Garber, D. W., G. Datta, M. Chaddha, M. N. Palgunachari, S. Y. Hama, M. Navab, A. M. Fogelman, J. P. Segrest, and G. M. Anantharamaiah. 2001. A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis. J. Lipid Res. 42: 545-552.
8. Venkatachalapathi, Y. V., M. C. Phillips, R. M. Epand, R. F. Epand, E. M. Tytler, J. P. Segrest, and G. M. Anantharamaiah. 1993. Effect of end group blockage on the properties of a class A amphipathic helical peptide. Proteins. 15: 349-359.
9. Cabana, V. G., J. N. Siegel, and S. M. Sabesin. 1989. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J. Lipid Res. 30: 39-49.
10. Reardon, C. A., L. Blachowicz, T. White, V. Cabana, Y. Wang, J. Lukens, J. Bluestone, and G. S. Getz. 2001. Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21: 1011-1016.
11. Maliwal, B. P., and F. E. Guthrie. 1982. In vitro uptake and transfer of chlorinated hydrocarbons among human lipoproteins. J. Lipid Res. 23: 474-479.
12. Fisher, W. R., M. G. Hammond, M. C. Mengel, and G. L. Warmke. 1975. A genetic determinant of the phenotypic variance of the molecular weight of low density lipoprotein. Proc. Natl. Acad. Sci. USA. 72: 2347-2351.
13. Cabana, V. G., C. A. Reardon, N. Feng, S. Neath, J. Lukens, and G. S. Getz. 2003. Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response. J. Lipid Res. 44: 780-792.
14. Lapenna, D., G. Ciofani, S. D. Pierdomenico, M. A. Giamberardino, and F. Cuccurullo. 2001. Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. Free Radic. Biol. Med. 31: 331-335.
15. Aviram, M., and J. Vaya. 2001. Markers for low-density lipoprotein oxidation. Methods Enzymol. 335: 244-256.
16. Jiao, S., T. G. Cole, R. T. Kitchens, B. Pfleger, and G. Schonfeld. 1990. Genetic heterogeneity of lipoproteins in inbred strains of mice: analysis by gel-permeation chromatography. Metabolism. 39: 155-160.
17. Van Lenten, B. J., A. C. Wagner, C-L. Jung, P. Ruchala, A. J. Waring, R. I. Lehrer, A. D. Watson, S. Hama, M. Navab, G. M. Anantharamaiah, et al. 2008. Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. J. Lipid Res. 49: 2302-2311.
18. Zhang, R., L. Barker, D. Pinchev, J. Marshall, M. Rasamoelisolo, C. Smith, P. Kupchak, I. Kireeva, L. Ingratta, and G. Jackowski. 2004. Mining biomarkers in human sera using proteomic tools. Proteomics. 4: 244-256.
19. Rother, R. P., L. Bell, P. Hillmen, and M. T. Gladwin. 2005. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 293: 1653-1662.
20. Navab, M., G. M. Anantharamaiah, S. Hama, D. W. Garber, M. Chaddha, G. Hough, R. Lallone, and A. M. Fogelman. 2002. Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation. 105: 290-292.
21. Navab, M., G. M. Anantharamaiah, S. T. Reddy, S. Hama, G. Hough, V. R. Grijalva, A. C. Wagner, J. S. Frank, G. Datta, D. Garber, et al. 2004. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Circulation. 109: 3215-3220.
22. Wool, G. D., and C. A. Reardon. 2007. The influence of acute phase proteins on murine atherosclerosis. Curr. Drug Targets. 8: 1203-1214.
23. Van Lenten, B. J., A. C. Wagner, M. Navab, G. M. Anantharamaiah, S. Hama, S. T. Reddy, and A. M. Fogelman. 2007. Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits. J. Lipid Res. 48: 2344-2353.
24. Li, X., K. Y. Chyu, J. R. Faria Neto, J. Yano, N. Nathwani, C. Ferreira, P. C. Dimayuga, B. Cercek, S. Kaul, and P. K. Shah. 2004. Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice. Circulation. 110: 1701-1705.
25. Copeland, B. E., P. J. Dyer, and A. J. Pesce. 1989. Hemoglobin by first derivative spectrophotometry: extent of hemolysis in plasma and serum collected in vacuum container devices. Ann. Clin. Lab. Sci. 19: 383-388.
26. Sethi AA, JA Stonik, SJ Demosky, and AT Remaley. 2006. Abstract 1203: Complexation of an apoA-I mimetic peptide with phospholipid increases ABCA1-specific cholesterol efflux. Circulation. 114: II 225.
27. Kee, P., K. A. Rye, J. L. Taylor, P. H. Barrett, and P. J. Barter. 2002. Metabolism of apoA-I as lipid-free protein or as component of discoidal and spherical reconstituted HDLs: studies in wild-type and hepatic lipase transgenic rabbits. Arterioscler. Thromb. Vasc. Biol. 22: 1912-1917.
28. Maack, T., V. Johnson, S. T. Kau, J. Figueiredo, and D. Sigulem. 1979. Renal filtration, transport, and metabolism of low-molecular weight proteins: a review. Kidney Int. 16: 251-270.